Comparison of Ranibizumab and Bevacizumab for Macular Edema Secondary to Retinal Vein Occlusions in Routine Clinical Practice.
暂无分享,去创建一个
Justis P. Ehlers | Rishi P. Singh | P. Kaiser | A. Rachitskaya | A. Yuan | S. Srivastava | A. Schachat | J. Ehlers | K. Wai | Fabiana Q. Silva | A. Babiuch | Mehnaz Khan | R. Deasy
[1] M. Neudorfer,et al. Bevacizumab treatment of macular edema in CRVO and BRVO: long-term follow-up. (BERVOLT study: Bevacizumab for RVO long-term follow-up) , 2016, Graefe's Archive for Clinical and Experimental Ophthalmology.
[2] P. Stavrou,et al. One-year outcome of bevacizumab therapy for chronic macular edema in central and branch retinal vein occlusions in real-world clinical practice in the UK , 2015, Clinical ophthalmology.
[3] Bradley T. Smith,et al. Bevacizumab Versus Ranibizumab in the Treatment of Macular Edema Due to Retinal Vein Occlusion: 6-Month Results of the CRAVE Study. , 2015, Ophthalmic surgery, lasers & imaging retina.
[4] YangChang-Sue,et al. Combination therapy with intravitreal bevacizumab and macular grid and scatter laser photocoagulation in patients with macular edema secondary to branch retinal vein occlusion. , 2015 .
[5] T. Das,et al. A randomised, double-masked, controlled study of the efficacy and safety of intravitreal bevacizumab versus ranibizumab in the treatment of macular oedema due to branch retinal vein occlusion: MARVEL Report No. 1 , 2015, British Journal of Ophthalmology.
[6] T. Wong,et al. Randomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion. , 2014, American journal of ophthalmology.
[7] T. Peto,et al. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3. , 2012, Archives of ophthalmology.
[8] M. Michaelis,et al. Comparison of cytokine levels from undiluted vitreous of untreated patients with retinal vein occlusion , 2012, Acta ophthalmologica.
[9] G. Yancopoulos,et al. Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab , 2012, Angiogenesis.
[10] J. Seland,et al. Efficacy of ranibizumab in patients with macular edema secondary to central retinal vein occlusion: results from the sham-controlled ROCC study. , 2010, American journal of ophthalmology.
[11] P. Rosenfeld,et al. NOVEL METHOD FOR ANALYZING SNELLEN VISUAL ACUITY MEASUREMENTS , 2010, Retina.
[12] Sarah Gray,et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. , 2010, Ophthalmology.
[13] P. Campochiaro,et al. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. , 2010, Ophthalmology.
[14] Y. Hata,et al. Comprehensive Analysis of Inflammatory Immune Mediators in Vitreoretinal Diseases , 2009, PloS one.
[15] Ingrid U Scott,et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. , 2009, Archives of ophthalmology.
[16] A. Barone,et al. BEVACIZUMAB COMPARED WITH MACULAR LASER GRID PHOTOCOAGULATION FOR CYSTOID MACULAR EDEMA IN BRANCH RETINAL VEIN OCCLUSION , 2009, Retina.
[17] L. Damico,et al. DEVELOPMENT OF RANIBIZUMAB, AN ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIGEN BINDING FRAGMENT, AS THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION , 2006, Retina.
[18] Kenneth J. Hillan,et al. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer , 2004, Nature Reviews Drug Discovery.
[19] P. Campochiaro,et al. Cellular mechanisms of blood-retinal barrier dysfunction in macular edema , 2004, Documenta Ophthalmologica.
[20] I. Cree,et al. Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion. , 2002, Archives of ophthalmology.
[21] David J. Wilson,et al. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report. , 1995, Ophthalmology.